Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| DIM (Diindolylmethane) | Melatonin | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 100-200mg DIM daily | 0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision) |
| Timing | With meals (fat enhances absorption). Consistent daily dosing for estrogen metabolism modulation. | 30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking. |
| Cycle Duration | ongoing or cycle 8-12 weeks on, 4 weeks off | Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision |
| Evidence Level | moderate_human | strong_human |
DIM is formed from indole-3-carbinol (I3C, from cruciferous vegetables) via acid condensation in the stomach. It modulates estrogen metabolism by promoting the 2-hydroxylation pathway (producing 2-hydroxyestrone, considered 'protective' estrogen) over the 16alpha-hydroxylation pathway (producing 16alpha-hydroxyestrone, considered proliferative) and the 4-hydroxylation pathway (producing 4-hydroxyestrone, genotoxic). DIM binds the aryl hydrocarbon receptor (AhR), inducing Phase I (CYP1A1, CYP1A2) and Phase II enzymes that facilitate estrogen detoxification. It also inhibits aromatase and has anti-androgen receptor effects (competitive binding).
100-200mg DIM daily
With meals (fat enhances absorption). Consistent daily dosing for estrogen metabolism modulation.
ongoing or cycle 8-12 weeks on, 4 weeks off
Melatonin (N-acetyl-5-methoxytryptamine) is synthesized from serotonin in the pineal gland, regulated by the suprachiasmatic nucleus (SCN) via the retinohypothalamic tract. It binds MT1 and MT2 G-protein coupled receptors: MT1 activation suppresses neuronal firing in the SCN (sleep onset), while MT2 modulates circadian phase shifting. Beyond sleep, melatonin is a potent antioxidant that scavenges hydroxyl radicals, peroxynitrite, and singlet oxygen, and upregulates antioxidant enzymes (GPx, SOD, catalase) via Nrf2. It has anti-inflammatory properties (NF-kB suppression), immunomodulatory effects, oncostatic activity (anti-proliferative in several cancer types), and mitochondrial protective functions.
0.3-1mg for sleep onset (physiological); 3-5mg for jet lag; 10-20mg for oncological adjunct (under supervision)
30-60 minutes before desired sleep onset. For circadian phase advance: 4-6 hours before desired bedtime. Sublingual for faster onset. Dim lights 1-2 hours before taking.
Short-term for jet lag (3-5 days); ongoing at low dose for circadian support if needed; extended for oncological use under supervision
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →